Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
03/01/2001 | WO2001014417A2 Pesticidal proteins |
03/01/2001 | WO2001014415A2 Egfh2 genes and gene products |
03/01/2001 | WO2001014414A2 Human abc2 transporter and uses thereof |
03/01/2001 | WO2001014410A1 Cloning of a pafr like 7tm receptor (axor11) |
03/01/2001 | WO2001014404A1 A polynucleotide encoding a human junctional adhesion protein (jam-2) |
03/01/2001 | WO2001014403A1 Mink2-modulator of potassium channels |
03/01/2001 | WO2001013948A1 Outer membrane protein a, peptidoglycan-associated lipoprotein, and murein lipoprotein as therapeutic targets for treatment of sepsis |
03/01/2001 | WO2001013932A2 Stimulation of sperm function |
03/01/2001 | WO2001013714A2 Prostatic cell line and animal model of a prostatic tumor |
03/01/2001 | WO2000077208A3 Gustatory receptors in drosophila |
03/01/2001 | WO2000075365A3 COMPOUNDS AND METHODS TO ENHANCE rAAV TRANSDUCTION |
03/01/2001 | WO2000073449B1 Dna encoding snorf33 receptor |
03/01/2001 | WO2000073445A3 Interleukin-1-receptor associated kinase-3 (irak3) |
03/01/2001 | WO2000073415A3 A method for the transfer of antigens to dendritic cells |
03/01/2001 | WO2000072885A9 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
03/01/2001 | WO2000071752A3 Assay for the detection of paclitaxel resistant cells in human tumors |
03/01/2001 | WO2000049168A3 Helper adenovirus / helper-dependent adenovirus vector system based on site-specific recombinase activity |
03/01/2001 | WO2000049162A8 Compositions and methods for non-targeted activation of endogenous genes |
03/01/2001 | WO2000048638A3 Multi-mutant diphtheria toxin vaccines |
03/01/2001 | WO1999036537A3 Fatty acid transport proteins |
03/01/2001 | DE19941186A1 Sequenz-spezifische DNA-Rekombination in eukaryotischen Zellen Sequence-specific DNA recombination in eukaryotic cells |
03/01/2001 | CA2816177A1 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
03/01/2001 | CA2589418A1 Human ctla-4 antibodies and their uses |
03/01/2001 | CA2383398A1 Skin care compositions and treatments |
03/01/2001 | CA2383371A1 P193 proteins and nucleic acids, and uses thereof |
03/01/2001 | CA2383074A1 Novel abc transporter and uses thereof |
03/01/2001 | CA2383073A1 Compositions and methods for improved cell culture |
03/01/2001 | CA2383063A1 Human abc2 transporter and uses thereof |
03/01/2001 | CA2382939A1 Method for growing stem cells |
03/01/2001 | CA2382795A1 Homologs of a pneumococcal protein and fragments for vaccines |
03/01/2001 | CA2382783A1 A polynucleotide encoding a human junctional adhesion protein (jam-2) |
03/01/2001 | CA2382693A1 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
03/01/2001 | CA2382674A1 Gas1 polypeptides |
03/01/2001 | CA2382483A1 Methods and compositions for the construction and use of fusion libraries |
03/01/2001 | CA2382221A1 Outer membrane protein a, peptidoglycan-associated lipoprotein, and murein lipoprotein as therapeutic targets for treatment of sepsis |
03/01/2001 | CA2382204A1 Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal |
03/01/2001 | CA2382183A1 New g-protein coupled receptor and dna sequences thereof |
03/01/2001 | CA2382146A1 Pgrp-l polynucleotides, polypeptides, and antibodies |
03/01/2001 | CA2382123A1 Novel polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
03/01/2001 | CA2382101A1 A transmembrane trap for isolating membrane bound proteins |
03/01/2001 | CA2380865A1 Novel response element |
03/01/2001 | CA2376406A1 G protein-coupled receptor expressed in brain |
03/01/2001 | CA2344469A1 Pesticidal proteins |
03/01/2001 | CA2316518A1 Use of ec-sod for treatment of systemic autoimmune diseases |
03/01/2001 | CA2304453A1 Use of ec-sod for treatment of systemic autoimmune diseases |
02/28/2001 | EP1078991A2 Methods for producing L-amino acids |
02/28/2001 | EP1078982A2 Cell culture module having sinusoid-like structure |
02/28/2001 | EP1078263A1 Method of direct selection of antigen-specific t cells |
02/28/2001 | EP1078095A1 Viral production process |
02/28/2001 | EP1078094A1 Methods and compositions for producing viral particles |
02/28/2001 | EP1078088A2 Transgenic plants with a modified activity of a plastidial adp/atp translocator |
02/28/2001 | EP1078080A1 Methods for producing polypeptides in filamentous fungal mutant cells |
02/28/2001 | EP1078078A1 Complex formed by a peptide and a major histocompatibility complex at the surface of phages |
02/28/2001 | EP1078075A2 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
02/28/2001 | EP1078073A1 Chitinase chitin-binding fragments |
02/28/2001 | EP1078064A2 Compounds from moraxella catarrhalis |
02/28/2001 | EP1078063A2 Basb029polynucleotide(s) and polypeptides from neisseria meningitis |
02/28/2001 | EP1078062A2 Growth-associated protease inhibitor heavy chain precursor |
02/28/2001 | EP1078060A2 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
02/28/2001 | EP1078057A2 Cell signaling proteins |
02/28/2001 | EP1078056A1 Rhotekin, a putative target for rho |
02/28/2001 | EP1078052A2 Noncloning technique for expressing a gene of interest |
02/28/2001 | EP1078046A1 97 human secreted proteins |
02/28/2001 | EP1078043A1 New apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines |
02/28/2001 | EP1078042A1 Production of megakaryocytes by co-culturing human mesenchymal stem cells with cd34+ cells |
02/28/2001 | EP1078041A1 Process for continuous purification and concentration of leukocytes from blood |
02/28/2001 | EP1078040A1 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors |
02/28/2001 | EP1078006A1 Diagnosis and treatment of hepatic disorders |
02/28/2001 | EP1078005A1 Methods for amyloid removal using anti-amyloid antibodies |
02/28/2001 | EP1077999A2 Moraxella catharralis proteins |
02/28/2001 | EP1077996A1 HUMAN EDG3sb GENE |
02/28/2001 | EP1077991A1 Secreted proteins and polynucleotides encoding them |
02/28/2001 | EP1077990A1 Pathogeniv tau mutations |
02/28/2001 | EP1077989A1 Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene |
02/28/2001 | EP1077599A1 PARTICLE BOMBARDMENT TRANSFORMATION OF $i(BRASSICA) |
02/28/2001 | EP1025204A4 Methods and materials for the growth of primate-derived primordial stem cells |
02/28/2001 | EP0769902A4 Methods for reducing hyperacute rejection of xenografts |
02/28/2001 | EP0632835B1 Transgenic plants displaying multiple virus resistance and a process for their production |
02/28/2001 | EP0576621B1 Ethanol production by recombinant hosts |
02/28/2001 | CN1285875A Mutated hydroxy-phenyl pyruvate dioxygenase, DNA sequence and method for obtaining herbicide-tolerant plants containing such gene |
02/28/2001 | CN1285873A orotidine 5'-phosphate decarboxylase-gene, gene construct containing said gene and the utilization thereof |
02/28/2001 | CN1285872A Gene associated with disease resistance in plants |
02/28/2001 | CN1285871A i (dull 1) coding for a starch synthase and uses thereof |
02/28/2001 | CN1285870A Novel pectate lyases |
02/28/2001 | CN1285846A Detection systems for registering protein interactions and functional relationships |
02/28/2001 | CN1285757A Biodegradable polymer scaffold |
02/28/2001 | CN1285754A Monoclonal human matural antibodies |
02/28/2001 | CN1285514A Medicine box bof testing anti-hepatitis C virus antibody |
02/28/2001 | CN1285138A Method for producing ginsent hairy root and ginsent seponin by hairy root agricillin A4 bacterial strain inducing explant of ginsent root |
02/28/2001 | CN1062599C Method for culturing glutimous banana tissue |
02/28/2001 | CN1062441C Composite living skin equivalents and preparation process thereof |
02/27/2001 | US6194637 Nucleotide and amino acid sequence; transgenic plants; increased transformation efficiency; genetic engineering |
02/27/2001 | US6194635 Producing sustained culture of pluripotent porcine embryonic germ cells by collecting primordial cells from embryo and culturing for more than 30 days; has stable phenotype for at least 60 days; transgenic swine |
02/27/2001 | US6194634 Apt-sensitive potassium channel gene-defective animals |
02/27/2001 | US6194560 Synthetic escherichia coli gene which encodes lt-b; the dna sequence is optimized for plant codon usage; feeds; foods |
02/27/2001 | US6194549 Partially purified preparation of pen5, a glycoprotein pair; for detecting and/or removing natural killer cells from a mixed population of cells |
02/27/2001 | US6194546 Influenza virus haemagglutinin which has a heterologous epitope at antigenic site a; vaccines against foot-and-mouth disease, poliovirus, human rhinovirus, hepatitis b virus, plasmodium and bacteria |
02/27/2001 | US6194389 Particle-mediated bombardment of DNA sequences into tissue to induce an immune response |
02/27/2001 | US6194385 Calcium-binding protein |
02/27/2001 | US6194212 Increasing gene expression by transducing eukaryotic cells with retrovirus vector having heterologous gene linked to regulatory sequence and scaffold attachment region of human interferon-beta gene, allowing cells to rest and express gene |